A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
Author(s):
Weinblatt, M.E.; Bingham, C.O.; Burmester, G.R.; Bykerk, V.P.; Furst, D.E.; Mariette, X.; Heijde, D. van der; Vollenhoven, R. van; VanLunen, B.; Ecoffet, C.; Cioffi, C.; Emery, P.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-10-31
Language
English
Is part of
Arthritis and Rheumatology (2017), Vol. 69, no. 10, p. 1937-1948
